Promising Results for Chemo-Free Immunotherapy in Early-Stage Triple-Negative Breast Cancer
Phase 2 trial shows potential for immunotherapy without chemo in early TNBC, especially with high TILs.
Gastrointestinal Stromal Tumors
2 articles
INSIGHT Trial: Tailoring GIST Treatment with Precision Medicine
New trial evaluates ripretinib vs sunitinib in advanced GIST patients with specific KIT mutations
Ripretinib Shows Promise in Chinese GIST Patients: Efficacy and Safety Comparable to Sunitinib
Phase 2 trial finds ripretinib effective and safer than sunitinib for advanced GIST in Chinese patients.